{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:26:37Z","timestamp":1791282397886,"version":"4.1.0"},"reference-count":209,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.blre.2007.11.002","type":"journal-article","created":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T12:36:19Z","timestamp":1199709379000},"page":"155-172","source":"Crossref","is-referenced-by-count":95,"title":["Inherited traits affecting platelet function"],"prefix":"10.1016","volume":"22","author":[{"given":"Isabelle I.","family":"Salles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik B.","family":"Feys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brecht F.","family":"Iserbyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon F.","family":"De Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Vanhoorelbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Deckmyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2007.11.002_bib1","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI26674","article-title":"The molecular mechanisms that control thrombopoiesis","volume":"115","author":"Kaushansky","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.blre.2007.11.002_bib2","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1172\/JCI26891","article-title":"The biogenesis of platelets from megakaryocyte proplatelets","volume":"115","author":"Patel","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.blre.2007.11.002_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1474-5151(02)00038-5","article-title":"Platelets and cardiovascular disease","volume":"1","author":"Willoughby","year":"2002","journal-title":"European Journal of Cardiovascular Nursing"},{"key":"10.1016\/j.blre.2007.11.002_bib4","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1172\/JCI26989","article-title":"Structure and function of the platelet integrin alphaIIbbeta3","volume":"115","author":"Bennett","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.blre.2007.11.002_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.blre.2006.06.001","article-title":"Platelet-neutrophil-interactions: Linking hemostasis and inflammation","volume":"21","author":"Zarbock","year":"2007","journal-title":"Blood Reviews"},{"key":"10.1016\/j.blre.2007.11.002_bib6","unstructured":"Deckmyn H, Vanhoorelbeke K, Ulrichts H et al. Amplification loops and signal transduction pathways. eds. Leuven university Press, 75\u201391, 2003."},{"key":"10.1016\/j.blre.2007.11.002_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0092-8674(00)81607-4","article-title":"Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow","volume":"94","author":"Savage","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.blre.2007.11.002_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00062752-200303000-00008","article-title":"Von Willebrand factor","volume":"10","author":"Ruggeri","year":"2003","journal-title":"Current Opinion in Hematology"},{"key":"10.1016\/j.blre.2007.11.002_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","article-title":"Platelet-collagen interaction: is GPVI the central receptor?","volume":"102","author":"Nieswandt","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib10","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/j.1538-7836.2005.01429.x","article-title":"GPVI and integrin alphaIIb beta3 signaling in platelets","volume":"3","author":"Watson","year":"2005","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib11","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1538-7836.2005.01377.x","article-title":"Protease-activated receptors in hemostasis, thrombosis and vascular biology","volume":"3","author":"Coughlin","year":"2005","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib12","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/CIRCULATIONAHA.105.574830","article-title":"Protease-activated receptors in cardiovascular diseases","volume":"114","author":"Leger","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2007.11.002_bib13","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1046\/j.1538-7836.2003.00267.x","article-title":"Signaling events underlying thrombus formation","volume":"1","author":"Jackson","year":"2003","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib14","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/01.ATV.20.6.1661","article-title":"Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb\/IIIa interaction","volume":"20","author":"Wu","year":"2000","journal-title":"Arteriosclerosis, Thrombosis & Vascular Biology"},{"key":"10.1016\/j.blre.2007.11.002_bib15","doi-asserted-by":"crossref","first-page":"16900","DOI":"10.1073\/pnas.0608207103","article-title":"The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis","volume":"103","author":"Bergmeier","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.blre.2007.11.002_bib16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2141.2006.06343.x","article-title":"A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO","volume":"135","author":"Bolton-Maggs","year":"2006","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.blre.2007.11.002_bib17","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood.V91.12.4397","article-title":"Bernard-Soulier syndrome","volume":"91","author":"Lopez","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00001721-199402000-00013","article-title":"The platelet glycoprotein Ib-IX complex","volume":"5","author":"Lopez","year":"1994","journal-title":"Blood Coagulation & Fibrinolysis"},{"key":"10.1016\/j.blre.2007.11.002_bib19","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1073\/pnas.86.17.6773","article-title":"Human platelet glycoprotein IX: an adhesive prototype of leucine-rich glycoproteins with flank-center-flank structures","volume":"86","author":"Hickey","year":"1989","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.blre.2007.11.002_bib20","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.90.18.8327","article-title":"Human platelet glycoprotein V: characterization of the polypeptide and the related Ib-V-IX receptor system of adhesive, leucine-rich glycoproteins","volume":"90","author":"Hickey","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.blre.2007.11.002_bib21","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1073\/pnas.85.7.2135","article-title":"The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence","volume":"85","author":"Lopez","year":"1988","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.blre.2007.11.002_bib22","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1182\/blood.V69.5.1524.1524","article-title":"Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane","volume":"69","author":"Du","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1172-1-46","article-title":"Bernard-Soulier syndrome (Hemorrhagiparous thrombocytic dystrophy)","volume":"1","author":"Lanza","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.blre.2007.11.002_bib24","doi-asserted-by":"crossref","first-page":"31449","DOI":"10.1074\/jbc.273.47.31449","article-title":"Synthesis, assembly, and intracellular transport of the platelet glycoprotein Ib-IX-V complex","volume":"273","author":"Dong","year":"1998","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.blre.2007.11.002_bib25","doi-asserted-by":"crossref","first-page":"22076","DOI":"10.1074\/jbc.271.36.22076","article-title":"Identification of a mutation in a GATA binding site of the platelet glycoprotein Ibbeta promoter resulting in the Bernard-Soulier syndrome","volume":"271","author":"Ludlow","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2007.11.002_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00001721-200306000-00010","article-title":"Bernard-soulier syndrome with a homozygous 13 base pair deletion in the signal peptide-coding region of the platelet glycoprotein Ib(beta) gene","volume":"14","author":"Watanabe","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.blre.2007.11.002_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1538-7836.2005.01654.x","article-title":"Synthesis of GPIb beta with novel transmembrane and cytoplasmic sequences in a Bernard-Soulier patient resulting in GPIb-defective signaling in CHO cells","volume":"4","author":"Strassel","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2007.11.002_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1365-2141.2002.03544.x","article-title":"A Leu7Pro mutation in the signal peptide of platelet glycoprotein (GP)IX in a case of Bernard-Soulier syndrome abolishes surface expression of the GPIb-V-IX complex","volume":"118","author":"Lanza","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2007.11.002_bib29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1160\/TH04-04-0240","article-title":"A novel mutation in the transmembrane region of glyco-protein IX associated with Bernard-Soulier syndrome","volume":"92","author":"Wang","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2007.11.002_bib30","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1073\/pnas.050582097","article-title":"Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome","volume":"97","author":"Ware","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2007.11.002_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0301-472X(02)00774-9","article-title":"Absence of GPIbalpha is responsible for aberrant membrane development during megakaryocyte maturation: ultrastructural study using a transgenic model","volume":"30","author":"Poujol","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.blre.2007.11.002_bib32","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood-2002-03-0997","article-title":"Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome","volume":"100","author":"Kanaji","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib33","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2004-03-1127","article-title":"Genetic deletion of mouse platelet glycoprotein Ibbeta produces a Bernard-Soulier phenotype with increased alpha-granule size","volume":"104","author":"Kato","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.ATV.0000251992.47053.75","article-title":"Decreased thrombotic tendency in mouse models of the Bernard-Soulier syndrome","volume":"27","author":"Strassel","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2007.11.002_bib35","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1182\/blood.V94.12.4112","article-title":"Glycoprotein V-deficient platelets have undiminished thrombin responsiveness and Do not exhibit a Bernard-Soulier phenotype","volume":"94","author":"Kahn","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1365-2141.1997.d01-2109.x","article-title":"Ultrastructural analysis of the distribution of the vitronectin receptor (alpha v beta 3) in human platelets and megakaryocytes reveals an intracellular pool and labelling of the alpha-granule membrane","volume":"96","author":"Poujol","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2007.11.002_bib37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood.V85.3.727.bloodjournal853727","article-title":"Substitution of Val for Met at residue 239 of platelet glycoprotein Ib alpha in Japanese patients with platelet-type von Willebrand disease","volume":"85","author":"Takahashi","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib38","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1073\/pnas.88.11.4761","article-title":"Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease","volume":"88","author":"Miller","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2007.11.002_bib39","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.V81.7.1787.1787","article-title":"Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor","volume":"81","author":"Russell","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1160\/TH06-10-0579","article-title":"A second report of platelet-type von Willebrand disease with a Gly233Ser mutation in the GPIBA gene","volume":"97","author":"Nurden","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2007.11.002_bib41","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1182\/blood-2002-09-2942","article-title":"Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease","volume":"105","author":"Othman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib42","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood.V90.2.698","article-title":"Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met239 \u2013> Val) reported in patients with platelet-type von Willebrand disease","volume":"90","author":"Moriki","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0268-960X(02)00030-9","article-title":"Molecular basis of Glanzmann\u2019s Thrombasthenia and current strategies in treatment","volume":"16","author":"Bellucci","year":"2002","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2007.11.002_bib44","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V75.7.1383.1383","article-title":"Glanzmann\u2019s thrombasthenia: the spectrum of clinical disease","volume":"75","author":"George","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1172-1-10","article-title":"Glanzmann thrombasthenia","volume":"1","author":"Nurden","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.blre.2007.11.002_bib46","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1073\/pnas.85.22.8683","article-title":"Physical linkage of the genes for platelet membrane glycoproteins IIb and IIIa","volume":"85","author":"Bray","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2007.11.002_bib47","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1126\/science.2392682","article-title":"A beta 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation","volume":"249","author":"Loftus","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.blre.2007.11.002_bib48","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1016\/S0021-9258(19)50595-6","article-title":"A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site","volume":"267","author":"Bajt","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2007.11.002_bib49","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1172\/JCI115808","article-title":"A new variant of Glanzmann\u2019s thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg\u2014-214Trp mutation","volume":"89","author":"Lanza","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2007.11.002_bib50","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1182\/blood.V92.10.3710","article-title":"Involvement of Na+\/Ca2+ exchanger in inside-out signaling through the platelet integrin IIbbeta3","volume":"92","author":"Shiraga","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib51","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1073\/pnas.89.21.10169","article-title":"Ser-752\u2013>Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia","volume":"89","author":"Chen","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2007.11.002_bib52","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1182\/blood.V92.11.4178","article-title":"R to Q amino acid substitution in the GFFKR sequence of the cytoplasmic domain of the integrin IIb subunit in a patient with a Glanzmann\u2019s thrombasthenia-like syndrome","volume":"92","author":"Peyruchaud","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib53","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1172\/JCI119780","article-title":"Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex","volume":"100","author":"Wang","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2007.11.002_bib54","doi-asserted-by":"crossref","first-page":"38628","DOI":"10.1074\/jbc.M105737200","article-title":"Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation","volume":"276","author":"Chen","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2007.11.002_bib55","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1182\/blood.V98.8.2432","article-title":"A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype","volume":"98","author":"Ruiz","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI5487","article-title":"Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival","volume":"103","author":"Hodivala-Dilke","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2007.11.002_bib57","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1172\/JCI8905","article-title":"Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts","volume":"105","author":"McHugh","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2007.11.002_bib58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0102-27","article-title":"Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins","volume":"8","author":"Reynolds","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2007.11.002_bib59","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1073\/pnas.0307289101","article-title":"Increased primary tumor growth in mice null for beta3- or beta3\/beta5-integrins or selectins","volume":"101","author":"Taverna","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2007.11.002_bib60","first-page":"OR108","article-title":"Modulating murine platelet function by expressing integrin alphaIIbbeta3 locked-in its high affinity state","volume":"3","author":"Wilcox","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2007.11.002_bib61","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1182\/blood-2004-12-4619","article-title":"Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia","volume":"106","author":"Fang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib62","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.1016\/S1525-0016(16)44973-7","article-title":"Therapeutic expression of a platelet-specific integrin restores hemostasis in dogs with Glanzmann thrombasthenia","volume":"15","author":"Wilcox","year":"2007","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.blre.2007.11.002_bib63","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1172\/JCI117510","article-title":"Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder","volume":"94","author":"Hirata","year":"1994","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.blre.2007.11.002_bib64","first-page":"77","article-title":"Molecular characterization of a dominantly inherited bleeding disorder with impaired platelet responses to thromboxane A2","volume":"48","author":"Okuma","year":"1996","journal-title":"Polish Journal of Pharmacology"},{"key":"10.1016\/j.blre.2007.11.002_bib65","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000039758","article-title":"Arg60 Leu mutation in the first cytoplasmic loop of the platelet thromboxane A2 receptor is not essential for mediating inhibitory coupling between the receptor and adenylyl cyclase","volume":"104","author":"Fuse","year":"2000","journal-title":"Acta Haematologica"},{"key":"10.1016\/j.blre.2007.11.002_bib66","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1182\/blood.V81.4.994.994","article-title":"Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation","volume":"81","author":"Fuse","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib67","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1055\/s-0037-1614866","article-title":"Mutations of the platelet thromboxane A2 (TXA2) receptor in patients characterized by the absence of TXA2-induced platelet aggregation despite normal TXA2 binding activity","volume":"82","author":"Higuchi","year":"1999","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib68","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1476-5381.1985.tb16139.x","article-title":"Competitive antagonism at thromboxane receptors in human platelets","volume":"84","author":"Armstrong","year":"1985","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.blre.2007.11.002_bib69","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1172\/JCI5116","article-title":"Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2","volume":"102","author":"Thomas","year":"1998","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.blre.2007.11.002_bib70","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/CIRCULATIONAHA.105.591537","article-title":"Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice","volume":"113","author":"Babaev","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2007.11.002_bib71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1182\/blood-2003-10-3661","article-title":"TXAS-deleted mice exhibit normal thrombopoiesis, defective hemostasis, and resistance to arachidonate-induced death","volume":"104","author":"Yu","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib72","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1172\/JCI114318","article-title":"A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion","volume":"84","author":"Moroi","year":"1989","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.blre.2007.11.002_bib73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ajh.2830390107","article-title":"Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation","volume":"39","author":"Ryo","year":"1992","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.blre.2007.11.002_bib74","doi-asserted-by":"crossref","unstructured":"Arai M, Yamamoto N, Moroi M, et al, Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency.[erratum appears in Br J Haematol 1995 Apr;89(4):952]. British Journal of Haematology 1995;89:124\u201330.","DOI":"10.1111\/j.1365-2141.1995.tb08900.x"},{"key":"10.1016\/j.blre.2007.11.002_bib75","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood-2003-11-3842","article-title":"Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome","volume":"104","author":"Nurden","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib76","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1111\/j.1538-7836.2006.02173.x","article-title":"Characterization of a patient with glycoprotein (GP) VI deficiency possessing neither anti-GPVI autoantibody nor genetic aberration","volume":"4","author":"Kojima","year":"2006","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib77","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood.V91.2.491","article-title":"Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb\/IIIa, and von Willebrand factor do not","volume":"91","author":"Kehrel","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib78","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1160\/TH04-05-0312","article-title":"Defective collagen-induced platelet activation in two patients with malignant haemopathies is related to a defect in the GPVI-coupled signalling pathway","volume":"93","author":"Bellucci","year":"2005","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib79","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2141.2007.06603.x","article-title":"A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway","volume":"137","author":"Dunkley","year":"2007","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.blre.2007.11.002_bib80","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2003-03-0889","article-title":"Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood","volume":"103","author":"Siljander","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib81","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.thromres.2005.08.001","article-title":"GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism","volume":"118","author":"Lockyer","year":"2006","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.blre.2007.11.002_bib82","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/emboj\/20.9.2120","article-title":"Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen","volume":"20","author":"Nieswandt","year":"2001","journal-title":"EMBO Journal"},{"key":"10.1016\/j.blre.2007.11.002_bib83","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood-2003-03-0717","article-title":"The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion","volume":"102","author":"Kato","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib84","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20020945","article-title":"A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo","volume":"197","author":"Massberg","year":"2003","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.blre.2007.11.002_bib85","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/j.1538-7836.2006.02086.x","article-title":"Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis","volume":"4","author":"Konstantinides","year":"2006","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib86","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1182\/blood-2005-10-4244","article-title":"Thrombin overcomes the thrombosis defect associated with platelet GPVI\/FcRgamma deficiency","volume":"107","author":"Mangin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib87","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1182\/blood-2005-09-3687","article-title":"Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo","volume":"107","author":"Dubois","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib88","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/318470a0","article-title":"Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia","volume":"318","author":"Nieuwenhuis","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.blre.2007.11.002_bib89","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1182\/blood.V68.3.692.692","article-title":"Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading","volume":"68","author":"Nieuwenhuis","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib90","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1182\/blood.V71.4.1074.1074","article-title":"Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder","volume":"71","author":"Kehrel","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib91","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-0038-1653807","article-title":"Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder","volume":"73","author":"Handa","year":"1995","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib92","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9440(10)64185-5","article-title":"The alpha(2) integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis[see comment]","volume":"161","author":"Chen","year":"2002","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.blre.2007.11.002_bib93","doi-asserted-by":"crossref","first-page":"10789","DOI":"10.1074\/jbc.M112307200","article-title":"Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen","volume":"277","author":"Holtkotter","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.blre.2007.11.002_bib94","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2003-05-1391","article-title":"Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo","volume":"102","author":"Gruner","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib95","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1182\/blood-2003-04-1323","article-title":"The contributions of the alpha 2 beta 1 integrin to vascular thrombosis in vivo","volume":"102","author":"He","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib96","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2141.2001.03115-3.x","article-title":"Patients with congenital abnormality of platelet aggregation induced by Ca(2+) ionophores may have a defect of the platelet P2Y(12) receptor for ADP [comment]","volume":"115","author":"Cattaneo","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.blre.2007.11.002_bib97","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1073\/pnas.0437879100","article-title":"Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding","volume":"100","author":"Cattaneo","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.blre.2007.11.002_bib98","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1111\/j.1538-7836.2005.01554.x","article-title":"Impaired platelet function in a patient with P2Y12 deficiency caused by a mutation in the translation initiation codon","volume":"3","author":"Shiraga","year":"2005","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib99","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1515\/CCLM.2007.036","article-title":"Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis","volume":"45","author":"Remijn","year":"2007","journal-title":"Clinical Chemistry & Laboratory Medicine"},{"key":"10.1016\/j.blre.2007.11.002_bib100","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI12242","article-title":"Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs [see comment]","volume":"107","author":"Foster","year":"2001","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.blre.2007.11.002_bib101","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.pharmtox.46.120604.141207","article-title":"Regulation of platelet functions by P2 receptors","volume":"46","author":"Gachet","year":"2006","journal-title":"Annual Review of Pharmacology & Toxicology"},{"key":"10.1016\/j.blre.2007.11.002_bib102","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/13522","article-title":"Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice","volume":"5","author":"Fabre","year":"1999","journal-title":"Nature Medicine"},{"key":"10.1016\/j.blre.2007.11.002_bib103","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1538-7836.2003.00003.x","article-title":"Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice","volume":"1","author":"Hechler","year":"2003","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib104","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0037-1612955","article-title":"Human platelet Galphaq deficiency is associated with decreased Galphaq gene expression in platelets but not neutrophils","volume":"87","author":"Gabbeta","year":"2002","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/38284","article-title":"Defective platelet activation in G alpha(q)-deficient mice","volume":"389","author":"Offermanns","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.blre.2007.11.002_bib106","doi-asserted-by":"crossref","first-page":"45354","DOI":"10.1074\/jbc.M408962200","article-title":"Unresponsiveness of platelets lacking both Galpha(q) and Galpha(13). Implications for collagen-induced platelet activation","volume":"279","author":"Moers","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.blre.2007.11.002_bib107","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1090-3798(03)00102-8","article-title":"G protein diseases: newly recognized causes of metabolic encephalopathy","volume":"7","author":"Jaeken","year":"2003","journal-title":"European Journal of Paediatric Neurology"},{"key":"10.1016\/j.blre.2007.11.002_bib108","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1055\/s-0037-1616126","article-title":"Genetic variation of the extra-large stimulatory G protein alpha-subunit leads to Gs hyperfunction in platelets and is a risk factor for bleeding","volume":"86","author":"Freson","year":"2001","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib109","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/hmg\/ddg130","article-title":"Functional polymorphisms in the paternally expressed XLalphas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation","volume":"12","author":"Freson","year":"2003","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.blre.2007.11.002_bib110","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1182\/blood-2002-10-3080","article-title":"Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder","volume":"101","author":"Patel","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib111","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1172\/JCI12818","article-title":"Impaired activation of murine platelets lacking G alpha(i2)","volume":"108","author":"Jantzen","year":"2001","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.blre.2007.11.002_bib112","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood.V99.3.905","article-title":"Lineage-specific defect in gene expression in human platelet phospholipase C-beta2 deficiency","volume":"99","author":"Mao","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib113","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)00005-4","article-title":"Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors","volume":"13","author":"Wang","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.blre.2007.11.002_bib114","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/01.ATV.0000163184.02484.69","article-title":"Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity","volume":"25","author":"Nonne","year":"2005","journal-title":"Arteriosclerosis, Thrombosis & Vascular Biology"},{"key":"10.1016\/j.blre.2007.11.002_bib115","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1007\/s00018-004-4086-z","article-title":"The Wiskott-Aldrich syndrome","volume":"61","author":"Orange","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.blre.2007.11.002_bib116","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1749-6632.1972.tb16316.x","article-title":"Nature of the platelet defect in the Wiskott-Aldrich syndrome","volume":"201","author":"Baldini","year":"1972","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.blre.2007.11.002_bib117","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2141.1969.tb01383.x","article-title":"Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival","volume":"17","author":"Grottum","year":"1969","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.blre.2007.11.002_bib118","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0038-1648139","article-title":"X-linked thrombocytopenia and thrombocytopathia: attenuated Wiskott-Aldrich syndrome. Functional and morphological studies of platelets and lymphocytes","volume":"65","author":"Stormorken","year":"1991","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib119","doi-asserted-by":"crossref","unstructured":"Nurden AT, Nurden P, Inherited defects of platelet function. Reviews in Clinical & Experimental Hematology5, 314-34; quiz following 431, 2001.","DOI":"10.1046\/j.1468-0734.2001.00052.x"},{"key":"10.1016\/j.blre.2007.11.002_bib120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00130832-200312000-00003","article-title":"WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype","volume":"3","author":"Imai","year":"2003","journal-title":"Current Opinion in Allergy & Clinical Immunology"},{"key":"10.1016\/j.blre.2007.11.002_bib121","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrm2069","article-title":"The WASP-WAVE protein network: connecting the membrane to the cytoskeleton","volume":"8","author":"Takenawa","year":"2007","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.blre.2007.11.002_bib122","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.gt.3302440","article-title":"A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice","volume":"12","author":"Charrier","year":"2005","journal-title":"Gene Therapy"},{"key":"10.1016\/j.blre.2007.11.002_bib123","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/sj.gt.3302863","article-title":"Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients","volume":"14","author":"Charrier","year":"2007","journal-title":"Gene Therapy"},{"key":"10.1016\/j.blre.2007.11.002_bib124","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.blre.2005.12.003","article-title":"The gray platelet syndrome: clinical spectrum of the disease","volume":"21","author":"Nurden","year":"2007","journal-title":"Blood Reviews"},{"key":"10.1016\/j.blre.2007.11.002_bib125","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V98.5.1382","article-title":"Newly recognized cellular abnormalities in the gray platelet syndrome","volume":"98","author":"Drouin","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib126","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1182\/blood.V81.10.2626.2626","article-title":"Inherited abnormalities in platelet organelles and platelet formation and associated altered expression of low molecular weight guanosine triphosphate-binding proteins in the mouse pigment mutant gunmetal","volume":"81","author":"Swank","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib127","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood.V85.7.1781.bloodjournal8571781","article-title":"Inherited thrombocytopenia caused by reduced platelet production in mice with the gunmetal pigment gene mutation","volume":"85","author":"Novak","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib128","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.080517697","article-title":"Rab geranylgeranyl transferase alpha mutation in the gunmetal mouse reduces Rab prenylation and platelet synthesis","volume":"97","author":"Detter","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.blre.2007.11.002_bib129","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1365-2141.2002.03444.x","article-title":"Cell-specific abnormal prenylation of Rab proteins in platelets and melanocytes of the gunmetal mouse","volume":"117","author":"Zhang","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.blre.2007.11.002_bib130","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.20011522","article-title":"Zinc finger protein, Hzf, is required for megakaryocyte development and hemostasis","volume":"195","author":"Kimura","year":"2002","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.blre.2007.11.002_bib131","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1538-7836.2005.01524.x","article-title":"Molecular study of the hematopoietic zinc finger gene in three unrelated families with gray platelet syndrome","volume":"3","author":"Benit","year":"2005","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib132","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1182\/blood-2006-02-004101","article-title":"X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation","volume":"109","author":"Tubman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib133","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood.V89.4.1243","article-title":"Studies of a second family with the Quebec platelet disorder: evidence that the degradation of the alpha-granule membrane and its soluble contents are not secondary to a defect in targeting proteins to alpha-granules","volume":"89","author":"Hayward","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib134","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood.V98.2.257","article-title":"Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator","volume":"98","author":"Kahr","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib135","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1538-7836.2006.01877.x","article-title":"Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis","volume":"4","author":"Diamandis","year":"2006","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib136","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2003-11-4077","article-title":"Bleeding risks associated with inheritance of the Quebec platelet disorder","volume":"104","author":"McKay","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib137","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood-2003-01-0054","article-title":"Antithrombotic thrombocytes: ectopic expression of urokinase-type plasminogen activator in platelets","volume":"102","author":"Kufrin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib138","first-page":"698","article-title":"A novel genetic thrombocytopenia (Paris-Trousseau) associated with platelet inclusions, dysmegakaryopoiesis and chromosome deletion AT 11q23","volume":"316","author":"Favier","year":"1993","journal-title":"Comptes Rendus de L\u2019Academie des Sciences - Serie Iii, Sciences de la Vie"},{"key":"10.1016\/j.blre.2007.11.002_bib139","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajmg.a.30090","article-title":"The 11q terminal deletion disorder: a prospective study of 110 cases","volume":"129","author":"Grossfeld","year":"2004","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/j.blre.2007.11.002_bib140","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1160\/TH03-02-0120","article-title":"Paris-Trousseau syndrome : clinical, hematological, molecular data of ten new cases [see comment]","volume":"90","author":"Favier","year":"2003","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib141","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1172\/JCI21197","article-title":"FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau\/Jacobsen thrombopenia [see comment]","volume":"114","author":"Raslova","year":"2004","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.blre.2007.11.002_bib142","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ajmg.a.31146","article-title":"Molecular characterization of an 11q interstitial deletion in a patient with the clinical features of Jacobsen syndrome","volume":"140","author":"Wenger","year":"2006","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/j.blre.2007.11.002_bib143","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00439-006-0232-z","article-title":"Clinical and molecular genetic features of ARC syndrome","volume":"120","author":"Gissen","year":"2006","journal-title":"Human Genetics"},{"key":"10.1016\/j.blre.2007.11.002_bib144","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/ng1325","article-title":"Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome","volume":"36","author":"Gissen","year":"2004","journal-title":"Nature Genetics"},{"key":"10.1016\/j.blre.2007.11.002_bib145","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1182\/blood-2005-04-1356","article-title":"Requirement of VPS33B, a member of the Sec1\/Munc18 protein family, in megakaryocyte and platelet alpha-granule biogenesis","volume":"106","author":"Lo","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib146","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-2004-835674","article-title":"Molecular defects that affect platelet dense granules","volume":"30","author":"Gunay-Aygun","year":"2004","journal-title":"Seminars in Thrombosis & Hemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib147","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1182\/blood.V39.2.197.197","article-title":"Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia\u2013\u201cstorage pool disease","volume":"39","author":"Holmsen","year":"1972","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib148","first-page":"333","article-title":"Albinism and Hermansky-Pudlak syndrome in Puerto Rico","volume":"82","author":"Witkop","year":"1990","journal-title":"Boletin - Asociacion Medica de Puerto Rico"},{"key":"10.1016\/j.blre.2007.11.002_bib149","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1600-0854.2005.00299.x","article-title":"The cell biology of Hermansky-Pudlak syndrome: recent advances","volume":"6","author":"Di Pietro","year":"2005","journal-title":"Traffic"},{"key":"10.1016\/j.blre.2007.11.002_bib150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/499338","article-title":"A germline mutation in BLOC1S3\/reduced pigmentation causes a novel variant of Hermansky-Pudlak syndrome (HPS8)","volume":"78","author":"Morgan","year":"2006","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.blre.2007.11.002_bib151","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0749.2005.00289.x","article-title":"Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function","volume":"19","author":"Wei","year":"2006","journal-title":"Pigment Cell Research"},{"key":"10.1016\/j.blre.2007.11.002_bib152","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1538-7836.2005.01428.x","article-title":"Qualitative disorders of platelets and megakaryocytes","volume":"3","author":"Nurden","year":"2005","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1016\/j.blre.2007.11.002_bib153","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/mgme.1999.2927","article-title":"Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome","volume":"68","author":"Introne","year":"1999","journal-title":"Molecular Genetics & Metabolism"},{"key":"10.1016\/j.blre.2007.11.002_bib154","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood.V47.6.941.941","article-title":"Platelet function in the Chediak-Higashi syndrome","volume":"47","author":"Buchanan","year":"1976","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng0796-303","article-title":"Identification of the murine beige gene by YAC complementation and positional cloning","volume":"13","author":"Perou","year":"1996","journal-title":"Nature Genetics"},{"key":"10.1016\/j.blre.2007.11.002_bib156","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ng1196-307","article-title":"Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome [see comment]","volume":"14","author":"Nagle","year":"1996","journal-title":"Nature Genetics"},{"key":"10.1016\/j.blre.2007.11.002_bib157","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF03402003","article-title":"The Chediak-Higashi protein interacts with SNARE complex and signal transduction proteins","volume":"8","author":"Tchernev","year":"2002","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.blre.2007.11.002_bib158","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1021\/pr060407o","article-title":"Lysosomal Membranes from Beige Mice Contain higher Than Normal Levels of Endoplasmic Reticulum Proteins","volume":"6","author":"Zhang","year":"2007","journal-title":"Journal of proteome research"},{"key":"10.1016\/j.blre.2007.11.002_bib159","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1182\/blood.V70.3.620.620","article-title":"Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients","volume":"70","author":"Nieuwenhuis","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib160","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood-2006-08-040196","article-title":"The Slc35d3 gene, encoding an orphan nucleotide sugar transporter, regulates platelet-dense granules","volume":"109","author":"Chintala","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib161","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1073\/pnas.0609879104","article-title":"Rab27b regulates number and secretion of platelet dense granules","volume":"104","author":"Tolmachova","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.blre.2007.11.002_bib162","unstructured":"Van Geet C, Freson K, in 9th-UK-1st NL Platelet meeting 17 (King\u2019s College London, 2007)."},{"key":"10.1016\/j.blre.2007.11.002_bib163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09537100600800172","article-title":"Alpha-delta platelet storage pool deficiency in three generations","volume":"18","author":"White","year":"2007","journal-title":"Platelets"},{"key":"10.1016\/j.blre.2007.11.002_bib164","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbalip.2003.07.003","article-title":"Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids","volume":"1636","author":"Zwaal","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.blre.2007.11.002_bib165","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0002-9343(79)90392-9","article-title":"Isolated deficiency of platelet procoagulant activity","volume":"67","author":"Weiss","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2007.11.002_bib166","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/blood.V87.4.1409.bloodjournal8741409","article-title":"Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder","volume":"87","author":"Toti","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib167","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1055\/s-0037-1613576","article-title":"Store-mediated calcium entry in the regulation of phosphatidylserine exposure in blood cells from Scott patients","volume":"89","author":"Munnix","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2007.11.002_bib168","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2004-05-2056","article-title":"A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome","volume":"106","author":"Albrecht","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib169","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1182\/blood.V99.7.2434","article-title":"A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity","volume":"99","author":"Brooks","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1399-0004.1985.tb02209.x","article-title":"A new syndrome: thrombocytopathia, muscle fatigue, asplenia, miosis, migraine, dyslexia and ichthyosis","volume":"28","author":"Stormorken","year":"1985","journal-title":"Clin Genet"},{"key":"10.1016\/j.blre.2007.11.002_bib171","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1055\/s-0038-1649920","article-title":"Studies on the haemostatic defect in a complicated syndrome. An inverse Scott syndrome platelet membrane abnormality?","volume":"74","author":"Stormorken","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2007.11.002_bib172","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM199604253341703","article-title":"A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis [see comment]","volume":"334","author":"Weiss","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.blre.2007.11.002_bib173","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00210-003-0828-y","article-title":"Role of platelet glycoprotein polymorphisms in cardiovascular diseases","volume":"369","author":"Meisel","year":"2004","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"key":"10.1016\/j.blre.2007.11.002_bib174","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1182\/blood.V98.10.3159","article-title":"Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men","volume":"98","author":"Cadroy","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib175","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0002-9149(00)01136-X","article-title":"Meta-analysis of the association of platelet glycoprotein IIIa PlA1\/A2 polymorphism with myocardial infarction","volume":"86","author":"Zhu","year":"2000","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.blre.2007.11.002_bib176","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(06)68263-9","article-title":"Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls.[see comment]","volume":"367","author":"Ye","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2007.11.002_bib177","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/jama.297.14.1551","article-title":"Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study","volume":"297","author":"Morgan","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2007.11.002_bib178","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1172\/JCI114082","article-title":"The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33\/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing","volume":"83","author":"Newman","year":"1989","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.blre.2007.11.002_bib179","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/01.ATV.19.4.1142","article-title":"Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study","volume":"19","author":"Feng","year":"1999","journal-title":"Arteriosclerosis, Thrombosis & Vascular Biology"},{"key":"10.1016\/j.blre.2007.11.002_bib180","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.CIR.101.9.1013","article-title":"Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists [see comment]","volume":"101","author":"Michelson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2007.11.002_bib181","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1365-2141.2000.02300.x","article-title":"Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa)","volume":"110","author":"Andrioli","year":"2000","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.blre.2007.11.002_bib182","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1365-2141.1997.4973300.x","article-title":"Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphism","volume":"99","author":"Lasne","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.blre.2007.11.002_bib183","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood.V97.10.3093","article-title":"Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets","volume":"97","author":"Bennett","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib184","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.1365-2141.1999.01413.x","article-title":"Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2): no association with platelet fibrinogen binding","volume":"105","author":"Meiklejohn","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.blre.2007.11.002_bib185","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1161\/01.ATV.0000043664.48689.7F","article-title":"PlA polymorphism of integrin beta 3 differentially modulates cellular migration on extracellular matrix proteins","volume":"22","author":"Sajid","year":"2002","journal-title":"Arteriosclerosis, Thrombosis & Vascular Biology"},{"key":"10.1016\/j.blre.2007.11.002_bib186","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1172\/JCI6982","article-title":"The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions [see comment]","volume":"105","author":"Vijayan","year":"2000","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.blre.2007.11.002_bib187","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/153537020623100504","article-title":"Molecular mechanisms of prothrombotic risk due to genetic variations in platelet genes: Enhanced outside-in signaling through the Pro33 variant of integrin beta3","volume":"231","author":"Vijayan","year":"2006","journal-title":"Experimental Biology & Medicine"},{"key":"10.1016\/j.blre.2007.11.002_bib188","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1074\/jbc.M208680200","article-title":"Enhanced activation of mitogen-activated protein kinase and myosin light chain kinase by the Pro33 polymorphism of integrin beta 3","volume":"278","author":"Vijayan","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.blre.2007.11.002_bib189","doi-asserted-by":"crossref","first-page":"21756","DOI":"10.1074\/jbc.M500872200","article-title":"The Pro33 isoform of integrin beta3 enhances outside-in signaling in human platelets by regulating the activation of serine\/threonine phosphatases","volume":"280","author":"Vijayan","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.blre.2007.11.002_bib190","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature02976","article-title":"Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics [see comment]","volume":"432","author":"Xiao","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.blre.2007.11.002_bib191","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/sim.1375","article-title":"Goldschmidt-Clermont PJ,A meta-analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart disease","volume":"22","author":"Burr","year":"2003","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.blre.2007.11.002_bib192","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0735-1097(03)00781-2","article-title":"Platelet glycoprotein IIb\/IIIa Pl(A2)\/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study","volume":"42","author":"Bojesen","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.blre.2007.11.002_bib193","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1016\/S0021-9258(19)50199-5","article-title":"Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure\/function implications","volume":"267","author":"Lopez","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.blre.2007.11.002_bib194","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1182\/blood.V79.11.3086.3086","article-title":"Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ib alpha involved in platelet transfusion refractoriness","volume":"79","author":"Murata","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood.V95.1.205","article-title":"Threonine-145\/methionine-145 variants of baculovirus produced recombinant ligand binding domain of GPIbalpha express HPA-2 epitopes and show equal binding of von Willebrand factor","volume":"95","author":"Li","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib196","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.ATV.0000079510.23517.43","article-title":"von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism","volume":"23","author":"Ulrichts","year":"2003","journal-title":"Arteriosclerosis, Thrombosis & Vascular Biology"},{"key":"10.1016\/j.blre.2007.11.002_bib197","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00109-002-0386-7","article-title":"Polymorphisms of glycoprotein Ib affect the inhibition by aurintricarboxylic acid of the von Willebrand factor dependent platelet aggregation","volume":"80","author":"Boncler","year":"2002","journal-title":"Journal of Molecular Medicine"},{"key":"10.1016\/j.blre.2007.11.002_bib198","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood.V92.8.2771","article-title":"Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease","volume":"92","author":"Gonzalez-Conejero","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib199","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2141.2004.05349.x","article-title":"Platelet glycoprotein Ib alpha polymorphisms affect the interaction with von Willebrand factor under flow conditions","volume":"128","author":"Matsubara","year":"2005","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.blre.2007.11.002_bib200","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1182\/blood.V92.7.2382","article-title":"Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density [see comment]","volume":"92","author":"Kritzik","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib201","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1182\/blood.V97.6.1721","article-title":"Allele-dependent transcriptional regulation of the human integrin alpha2 gene","volume":"97","author":"Jacquelin","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib202","doi-asserted-by":"crossref","first-page":"23518","DOI":"10.1074\/jbc.M102019200","article-title":"Characterization of Inherited Differences in Transcription of the Human Integrin alpha 2 Gene","volume":"276","author":"Jacquelin","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.blre.2007.11.002_bib203","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1172\/JCI116849","article-title":"The human platelet alloantigens Br(a) and Brb are associated with a single amino acid polymorphism on glycoprotein Ia (integrin subunit alpha 2)","volume":"92","author":"Santoso","year":"1993","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.blre.2007.11.002_bib204","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1182\/blood.V94.12.4103","article-title":"A point mutation Thr(799)Met on the alpha(2) integrin leads to the formation of new human platelet alloantigen Sit(a) and affects collagen-induced aggregation","volume":"94","author":"Santoso","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib205","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/hq0102.100458","article-title":"The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease","volume":"22","author":"Kunicki","year":"2002","journal-title":"Arteriosclerosis. Thrombosis & Vascular Biology"},{"key":"10.1016\/j.blre.2007.11.002_bib206","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1161\/hc3801.096397","article-title":"Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction [see comment]","volume":"104","author":"Croft","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2007.11.002_bib207","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1182\/blood-2003-01-0231","article-title":"GPVI levels in platelets: relationship to platelet function at high shear","volume":"102","author":"Best","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib208","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1182\/blood-2002-08-2591","article-title":"The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression","volume":"101","author":"Joutsi-Korhonen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2007.11.002_bib209","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1161\/hq1001.096643","article-title":"Variation in human platelet glycoprotein VI content modulates glycoprotein VI-specific prothrombinase activity","volume":"21","author":"Furihata","year":"2001","journal-title":"Arteriosclerosis, Thrombosis & Vascular Biology"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X07000719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X07000719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:03:12Z","timestamp":1630468992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X07000719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":209,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0268960X07000719"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2007.11.002","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}